Selected article for: "defect repair and HS GC MS method"

Author: Li, Ling; Long, Jing; Li, Long; Cao, Huijuan; Tang, Tingting; Xi, Xinghua; Qin, Ling; Lai, Yuxiao; Wang, Xinluan
Title: Quantitative determination of residual 1,4-dioxane in three-dimensional printed bone scaffold
  • Document date: 2017_7_17
  • ID: qd2te842_55
    Snippet: Three-dimensional printing porous scaffolds are promising regenerative strategies for bone defect repair in orthopaedics [6, 7] . As a newly developed medical product, safety issues are considered as the most important ones. As a Class 2 solvent with less severe toxicity, content of residual 1,4-dioxane in the novel 3D printing PLGA/TCP scaffolds should be rigorously controlled according to international regulations, such as Chinese Pharmacopoeia.....
    Document: Three-dimensional printing porous scaffolds are promising regenerative strategies for bone defect repair in orthopaedics [6, 7] . As a newly developed medical product, safety issues are considered as the most important ones. As a Class 2 solvent with less severe toxicity, content of residual 1,4-dioxane in the novel 3D printing PLGA/TCP scaffolds should be rigorously controlled according to international regulations, such as Chinese Pharmacopoeia [26] , International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use [27] and United States Pharmacopoeia [28] . In this work, we firstly developed an HS-GC-MS method for testing 1,4-dioxane in PLGA/TCP porous scaffolds. It is an important file in medical device approval and registration. It has been applied as an enterprise standard to optimise the drying process of scaffolds and monitor the quality of scaffolds in the industrialisation process.

    Search related documents:
    Co phrase search for related documents
    • defect repair and enterprise standard: 1
    • defect repair and HS GC MS method: 1, 2
    • defect repair and important file: 1
    • defect repair and important one: 1
    • defect repair and industrialisation process: 1
    • defect repair and medical device: 1
    • defect repair and medical product: 1
    • defect repair and PLGA TCP scaffold: 1
    • defect repair and porous scaffold: 1, 2
    • defect repair and residual content: 1, 2
    • defect repair and severe toxicity: 1, 2
    • defect repair and TCP porous scaffold: 1
    • drying process and enterprise standard: 1
    • drying process and HS GC MS method: 1, 2
    • drying process and important file: 1
    • drying process and industrialisation process: 1
    • drying process and medical device: 1, 2
    • drying process and medical device approval: 1
    • drying process and PLGA TCP scaffold: 1